Effect of long-term administration of antidepressants on the lipid composition of brain plasma membranes

General Physiology and Biophysics

Volumn 24, Issue 2, 2005, Pages 221-236

  Fišar, Zdeněk ^a   Anders, M ^a   Tvrzicka E ^a   Stankova B ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Antidepressant; Cholesterol; Phospholipid; Plasma membrane; Rat brain

Indexed keywords

CHOLESTEROL; CITALOPRAM; DESIPRAMINE; LITHIUM CARBONATE; MAPROTILINE; MEMBRANE LIPID; MOCLOBEMIDE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANISOTROPY; ARTICLE; BRAIN MEMBRANE; BRAIN TISSUE; CELL MEMBRANE; CONTROLLED STUDY; CORRELATION FUNCTION; DOSE CALCULATION; DRUG MECHANISM; DRUG SELECTIVITY; FLUORESCENCE ANALYSIS; HYPOTHESIS; LIPID COMPOSITION; LONG TERM CARE; MALE; NEUROTRANSMISSION; NONHUMAN; RAT; STATISTICAL SIGNIFICANCE; VISCOSITY;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; MEMBRANE LIPIDS; PHOSPHOLIPIDS; RATS; RATS, WISTAR; TIME FACTORS;

ANIMALIA; RATTUS NORVEGICUS;

EID: 23944450103     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Barenholz Y. (2002): Cholesterol and other membrane active sterols: from membrane evolution to "rafts". Prog. Lipid Res. 41, 1-5
2. Bartlett, G. R., 1959. Phosphorus assay in column chromatography. J. Biol. Chem. 234, 466-468
3. Bobeszko M., Czajkowski R., Wójcik M., Sabała P., Lei L., Nalepa I., Barańska J. (2002): Modulation by cationic amphiphilic drugs of serine base-exchange, phosholipase D and intracellular calcium homeostasis in glioma C6 cells. Pol. J. Pharmacol. 54, 483-493
4. Burger K., Gimpl G., Fahrenholz F. (2000): Regulation of receptor function by cholesterol. Cell. Mol. Life Sci. 57, 1577-1592
5. 2 activity. Neurochem. Res. 23, 887-892
6. Fielding C. J., Fielding P. E. (2003): Relationship between cholesterol trafficking and signaling in rafts and caveolae. Biochim. Biophys. Acta 1610, 219-228
7. Fišar Z., Krulík R., Fuksová K., Sikora J. (1996): Imipramine distribution among red blood cells, plasma and brain tissue. Gen. Physiol. Biophys. 15, 51-64
8. Fišar Z., Fuksová K., Velenovská M. (2004): Binding of imipramine to phospholipid bilayers using radioligand binding assay. Gen. Physiol. Biophys. 23, 77-99
9. Fišar Z., Anders M., Kališová L. (2005): Effect pharmacologically selective antidepressants on serotonin uptake in rat platelets. Gen. Physiol. Biophys. 24, 113-128
10. Folch J., Lees M., Sloane Stanley G. H. (1957): A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497-509
11. Herbette L. G., Chester D. W., Rhodes D. G. (1986): Structural analysis of drug molecules in biological membranes. Biophys. J. 49, 91-94
12. Honegger U. E., Roscher A. A., Wiesmann U. N. (1983): Evidence for lysosomotropic action of desipramine in cultured human fibroblasts. J. Pharmacol. Exp. Ther. 225, 436-441
13. Jope R. S. (1999): Anti-bipolar therapy: mechanism of action of lithium. Mol. Psychiatry 4, 117-128
14. Kaiser R. D., London E. (1998): Location of diphenylhexatriene (DPH) and its derivatives within membranes: comparison of different fluorescence quenching analyses of membrane depth. Biochemistry 37, 8180-8190
15. Kanfer J. N., McCartney D. G. (1993): Modulation of the serine base exchange enzyme activity of rat brain membranes by amphiphilic cations and amphiphilic anions. J. Neurochem. 60, 1228-1235
16. Kato T., Inubushi T., Kato N. (1998): Magnetic resonance spectroscopy in affective disorders. J. Neuropsychiatry Clin. Neurosci. 10, 133-147
17. Koul A., Prasad R. (1996): Extraction of membrane lipids. In: Manual on Membrane Lipids. pp. 37-51, Springer, Heidelberg
18. Lakowicz J. R. (1999): Principles of Fluorescence Spectroscopy (2nd ed.), Kluwer Academic /Plenum Publishers, New York
19. Lee A. G. (2003): Lipid-protein interactions in biological membranes: a structural perspective. Biochim. Biophys. Acta 1612, 1-40
20. Lentz B. R. (1993): Use of fluorescent probes to monitor molecular order and motions within liposome bilayers. Chem. Phys. Lipids 64, 99-116
21. Li P. P., Warsh J. J., Stanacev N. Z. (1988): In vitro and ex vivo effects of antidepressants on rat brain membrane-bound phosphatidylinositol synthetase activity. Neurochem. Res. 13, 789-795
22. Lopez-Corcuera B., Gimenez C., Aragon C. (1988): Change of synaptic membrane lipid composition and fluidity by chronic administration of lithium. Biochim. Biophys. Acta 939, 467-475
23. Lowry O. H., Rosbrough N. J., Farr A. L., Randall R. J. (1951): Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275
24. Lüllmann-Rauch R., Nassberger L. (1983): Citalopram-induced generalized lipidosis in rats. Acta Pharmacol. Toxicol. (Copenh.) 52, 161-167
25. Maes M., Smith R., Christophe A., Vandoolaeghe E., Van Gastel A., Neels H., Demedts P., Wauters A., Meltzer H. Y. (1997): Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers. Acta Psychiatr. Scand. 95, 212-221
26. Manji H. K., Moore G. J., Chen G. (1999): Lithium at 50: have the neuroprotective effects of this unique cation been overlooked? Biol. Psychiatry 46, 929-940
27. Mitchell R. H., Hawthorne J. N. (1965): The site of diphosphoinositide synthesis in rat liver. Biochem. biophys. Res. Commun. 21, 333-338
28. Moor M., Honegger U. E., Wiesmann U. N. (1988): Organspecific, qualitative changes in the phospholipids composition of rats after chronic administration of the antidepressant drug desipramine. Biochem. Pharmacol. 37, 2035-2039
29. Navidi M., Yoa F. G., Sun G. Y. (1991): Brief chronic effects of lithium administration on rat brain phosphoinositides and phospholipids. J. Neurosci. Res. 28, 428-433
30. Ohvo-Rekilä H., Ramstedt B., Leppimäki P., Slotte J. P. (2002): Cholesterol interactions with phospholipids in membranes. Prog. Lipid Res. 41, 66-97
31. Pettegrew J. W., Short J. W., Woessner R. D., Strychor S., McKeag D. W., Armstrong J., Minshew N. J., Rush A. J. (1987): The effect of lithium on the membrane molecular dynamics of normal human erythrocytes. Biol. Psychiatry 22, 857-871
32. Pettegrew J. W., Panchalingam K., McClure R. J., Gershon S., Muenz L. R., Levine J. (2001): Effects of chronic lithium administration on rat brain phosphatidylinositol cycle constituents, membrane phospholipids and amino acids. Bipolar Disord. 3, 189-201
33. Pfrieger F. W. (2003): Role of cholesterol in synapse formation and function. Biochim. Biophys. Acta 1610, 271-280
34. Plášek J., Jarolím P. (1987): Interaction of the fluorescent probe 1,6-diphenyl-1,3,5-hexatriene with biomembranes. Gen. Physiol. Biophys. 6, 425-437
35. Prendergast F. G., Haugland R. P., Callahan P. J. (1981): 1-[4-(trimethyamino)phenyl]-6-phenylhexa-1,3,5-triene: synthesis, fluorescence properties, and use as a fluorescence probe of lipid bilayers. Biochemistry 20, 7333-7338
36. Racagni G., Brunello N. (1984): Transynaptic mechanisms in the action of antidepressant drugs. Trends Pharmacol. Sci. 5, 527-531
37. Rando R. R. (1988): Regulation of protein kinase-C activity by lipids. FASEB J. 2, 2348-2355
38. Sandermann H., Duncan T. M. (1991): Lipid-dependent membrane enzymes - kinetic modeling of the activation of protein-kinase-C by phosphatidylserine. Biochim. Biophys. Acta 1069, 235-240
39. Sanganahalli B. G., Joshi P. G., Joshi N. B. (2000): Differential effects of tricyclic antidepressant drugs on membrane dynamics - a fluorescence spectroscopic study. Life Sci. 68, 81-90
40. Scanlon S. M., Williams D. C., Schloss P. (2001): Membrane cholesterol modulates serotonin transporter activity. Biochemistry 40, 10507-10513
41. Scott L., Schell M. J., Hubbard A. L. (1993): I. Isolation and analysis. In: Methods in Molecular Biology (Eds. J. M. Graham and J. A. Higgins), Biomembrane Protocols, Vol. 19, Humana Press, Totowa, New Jersey
42. Seydel J. K., Coats E. A., Cordes H. P., Wiese M. (1994): Drug membrane interaction and the importance for drug transport, distribution, accumulation, efficacy and resistance. Arch. Pharm. (Weinheim) 327, 601-610
43. Shinitzky M. (1984): Membrane fluidity and receptor function. In: Membrane Fluidity (Eds. M. Kates and L. A. Manson), pp. 585-601, Plenum Publ. Corp., New York
44. Singh I. N., Massarelli R., Kanfer J. N. (1992): Modulation of phosphatidylserine homeostasis by amphiphilic cations in a human neuronal cell line, LA-N-2. J. Lipid Mediat. 5, 301-311
45. Stahl S. M. (2000): Essential Psychopharmacology. Neuroscientific Basis and Practical Applications (2nd ed.), Cambridge University Press, Cambridge
46. Stoffel P., Burkart T., Honegger U. E., Wiesmann U. N. (1987): Subcellular distribution of the antidepressant drug desipramine in cultured human fibroblasts after chronic administration. Drug-effect on the subcellular distribution of accumulated phospholipids. Biochem. Pharmacol. 36, 655-662
47. Sulser F., Janowsky A. J., Okada F., Manier D. H., Mobley P. L. (1983): Regulation of recognition and action function of the norepinephrine (NE) receptor-coupled adenylate cyclase system in brain: implications for the therapy of depression. Neuropharmacology 22, 425-431
48. Toplak H., Zuehlke R., Loidl S., Hermetter A., Honegger U. E., Wiesmann U. N. (1990): Single and multiple desipramine exposures of cultured cells. Changes in cellular anisotropy and in lipid composition of whole cells and of plasma membranes. Biochem. Pharmacol. 39, 1437-1443
49. +)-stimulated ATPase and acetylcholinesterase activities of dog brain synaptosomal plasma-membranes. Biochem. J. 220, 301-307
50. Tvrzická E., Mareš P., Písaříková A., Novakovic J., Hrabák P. (1991): Simplified gas chromatographic method for the simultaneous determination of phytosterols and cholesterol. J. Chromatogr. 563, 188-192
51. Xia Z., Ying G., Hansson A. L., Karlsson H., Xie Y., Bergstrand A., DePierre J. W., Nässberger L. (2000): Antidepressant-induced lipidosis with special reference to tricyclic compounds. Prog. Neurobiol. 60, 501-512